EMA
approval
· 2023-10-13
New treatment option for heavily pre-treated multiple myeloma patients
Summary
The EMA announces a new treatment option for heavily pre-treated multiple myeloma patients, expanding options for this difficult-to-treat group.
Upgrade for the full analysis, importance score, and drug timeline.